Company profile for CNS Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CNS is developing Berubicin, a breakthrough drug for the treatment of the most deadly form of brain cancer. Berubicin was created at MD Anderson Cancer Center, the largest cancer and research institute in the world. Berubicin’s Phase I clinical trial yielded promising results showing clinical activity in 44% of patients*. Berubicin is the first of its class of drugs to cross the blood brain barrier (BBB) and reach cancer cel...
CNS is developing Berubicin, a breakthrough drug for the treatment of the most deadly form of brain cancer. Berubicin was created at MD Anderson Cancer Center, the largest cancer and research institute in the world. Berubicin’s Phase I clinical trial yielded promising results showing clinical activity in 44% of patients*. Berubicin is the first of its class of drugs to cross the blood brain barrier (BBB) and reach cancer cells in brain tumor patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2100 West Loop South Freeway , Houston, TX
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-17/cns-pharmaceuticals-announces-ceo-transition

PHARMIWEB
17 Dec 2025

https://www.pharmiweb.com/press-release/2025-11-17/cns-pharmaceuticals-reports-third-quarter-2025-financial-results-and-provides-corporate-update

PHARMIWEB
17 Nov 2025

https://www.pharmiweb.com/press-release/2025-11-10/cns-pharmaceuticals-announces-acceptance-of-three-abstracts-for-poster-presentation-at-the-society-o

PHARMIWEB
10 Nov 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cns-pharmaceuticals-to-present-at-the-h.c.-wainwright-27th-annual-glo-1068031

ACCESSWIRE
03 Sep 2025

https://www.pharmiweb.com/press-release/2025-08-15/cns-pharmaceuticals-reports-second-quarter-2025-financial-results-and-provides-corporate-update

PHARMAWEB
15 Aug 2025

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cns-pharmaceuticals-to-participate-in-the-virtual-investor-%22what%e2%80%99s-yo-1051182

ACCESSWIRE
22 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty